Cite
HARVARD Citation
Kong, G. et al. (2016). Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma. Journal of pediatric hematology/oncology. 38 (2), p. . [Online].